Sagimet Biosciences target price raised to $38 from $33
SGMT•Oppenheimer raised its target price for Sagimet Biosciences to $38 from $33.
Related News
IBA agrees to distribute Telix unit ARTMS’ QUANTM cyclotron technology worldwide
TLX•
RBC cuts W. P. Carey Inc. target price to $67 from $77
WPC•
BCE Inc: National Bank of Canada cuts target price to C$36 from C$38
BCE•
Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal
REGN•
Eni completes Plenitude shareholding, governance reorganization
E•